ArticleInfectious diseases and therapy2021

Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern.

Marco Falcone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.